India · Delayed Price · Currency is INR NSE:QMSMEDI Statistics
Total Valuation
NSE:QMSMEDI has a market cap or net worth of INR 3.29 billion. The enterprise value is 4.06 billion.
| Market Cap | 3.29B |
| Enterprise Value | 4.06B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | Sep 23, 2026 |
Share Statistics
NSE:QMSMEDI has 19.34 million shares outstanding. The number of shares has increased by 11.45% in one year.
| Current Share Class | 19.34M |
| Shares Outstanding | 19.34M |
| Shares Change (YoY) | +11.45% |
| Shares Change (QoQ) | -49.31% |
| Owned by Insiders (%) | 68.00% |
| Owned by Institutions (%) | n/a |
| Float | 6.19M |
Valuation Ratios
The trailing PE ratio is 31.15.
| PE Ratio | 31.15 |
| Forward PE | n/a |
| PS Ratio | 1.80 |
| PB Ratio | 2.89 |
| P/TBV Ratio | 4.73 |
| P/FCF Ratio | 24.12 |
| P/OCF Ratio | 16.94 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.91, with an EV/FCF ratio of 29.81.
| EV / Earnings | 37.48 |
| EV / Sales | 2.22 |
| EV / EBITDA | 14.91 |
| EV / EBIT | 17.56 |
| EV / FCF | 29.81 |
Financial Position
The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.65.
| Current Ratio | 1.56 |
| Quick Ratio | 0.82 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | 2.73 |
| Debt / FCF | 5.46 |
| Interest Coverage | 3.39 |
Financial Efficiency
Return on equity (ROE) is 10.78% and return on invested capital (ROIC) is 9.26%.
| Return on Equity (ROE) | 10.78% |
| Return on Assets (ROA) | 6.82% |
| Return on Invested Capital (ROIC) | 9.26% |
| Return on Capital Employed (ROCE) | 18.06% |
| Weighted Average Cost of Capital (WACC) | 7.66% |
| Revenue Per Employee | 1.77M |
| Profits Per Employee | 104,685 |
| Employee Count | 1,037 |
| Asset Turnover | 0.86 |
| Inventory Turnover | 2.17 |
Taxes
In the past 12 months, NSE:QMSMEDI has paid 47.86 million in taxes.
| Income Tax | 47.86M |
| Effective Tax Rate | 27.35% |
Stock Price Statistics
The stock price has increased by +81.43% in the last 52 weeks. The beta is 0.66, so NSE:QMSMEDI's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | +81.43% |
| 50-Day Moving Average | 176.43 |
| 200-Day Moving Average | 116.52 |
| Relative Strength Index (RSI) | 45.43 |
| Average Volume (20 Days) | 25,013 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:QMSMEDI had revenue of INR 1.83 billion and earned 108.56 million in profits. Earnings per share was 5.46.
| Revenue | 1.83B |
| Gross Profit | 903.78M |
| Operating Income | 231.76M |
| Pretax Income | 175.01M |
| Net Income | 108.56M |
| EBITDA | 272.89M |
| EBIT | 231.76M |
| Earnings Per Share (EPS) | 5.46 |
Balance Sheet
The company has 66.60 million in cash and 744.81 million in debt, with a net cash position of -678.21 million or -35.07 per share.
| Cash & Cash Equivalents | 66.60M |
| Total Debt | 744.81M |
| Net Cash | -678.21M |
| Net Cash Per Share | -35.07 |
| Equity (Book Value) | 1.14B |
| Book Value Per Share | 29.67 |
| Working Capital | 507.45M |
Cash Flow
In the last 12 months, operating cash flow was 194.37 million and capital expenditures -57.87 million, giving a free cash flow of 136.50 million.
| Operating Cash Flow | 194.37M |
| Capital Expenditures | -57.87M |
| Depreciation & Amortization | 41.13M |
| Net Borrowing | -24.74M |
| Free Cash Flow | 136.50M |
| FCF Per Share | 7.06 |
Margins
Gross margin is 49.32%, with operating and profit margins of 12.65% and 5.92%.
| Gross Margin | 49.32% |
| Operating Margin | 12.65% |
| Pretax Margin | 9.55% |
| Profit Margin | 5.92% |
| EBITDA Margin | 14.89% |
| EBIT Margin | 12.65% |
| FCF Margin | 7.90% |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.29%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 0.29% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 9.16% |
| FCF Payout Ratio | 7.08% |
| Buyback Yield | -11.45% |
| Shareholder Yield | -11.16% |
| Earnings Yield | 3.21% |
| FCF Yield | 4.15% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |